Neo-Sinefrina (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride, the active ingredient in Neo‑Sinefrina, is a sympathomimetic (alpha‑1 adrenergic agonist) presented as a nasal formulation for topical nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children.

GNH USA supplies Neo‑Sinefrina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neo‑Sinefrina acts on the nasal mucosa to reduce swelling and improve airflow in conditions that cause congestion.

Common cold nasal congestion: reduces swelling of nasal tissues to ease breathing. Sinusitis‑related congestion: alleviates blockage by constricting nasal blood vessels. Allergic rhinitis: diminishes nasal swelling and congestion caused by allergic inflammation.

Phenylephrine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal burning or stinging sensation - Dryness of the nasal mucosa - Sneezing - Headache - Mild palpitations or increased heart rate - Transient rise in blood pressure

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis - Cardiac arrhythmias - Allergic reactions including rash, itching, swelling, or anaphylaxis - Nasal septum perforation with prolonged misuse

Before using Neo‑Sinefrina, consider the following safety measures.

Pregnancy: consult a healthcare professional before use. Breastfeeding: discuss potential risks with a physician. Cardiovascular disease: use with caution and monitor blood pressure. Hypertension: avoid or limit use unless advised by a clinician. Drug interactions: review concomitant medications with a pharmacist. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Phenylephrine Hydrochloride can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other sympathomimetic decongestants: additive vasoconstrictive effects. - Tricyclic antidepressants: may increase blood pressure.

Moderate Interactions (Monitor Closely):\n- Beta‑blockers: may blunt cardiovascular response. - Antihypertensive agents: possible reduction in efficacy. - Selective serotonin reuptake inhibitors (SSRIs): monitor for elevated blood pressure.